Morgan Stanley has upgraded PTC Therapeutics (PTCT), while downgrading Immuneering (IMRX) and Amicus Therapeutics (FOLD).

Key Takeaways Morgan Stanley kept Apple as its "Top Pick" for 2025 as the bank sees the tech giant's artificial intelligence ...

Fintel reports that on December 13, 2024, Morgan Stanley upgraded their outlook for TaskUs (NasdaqGS:TASK) from Equal-Weight ...

Morgan Stanley表示，TaskUs的竞争护城河和预期加速的收入增长相结合，可能会引起投资者对该股票的更多兴趣。该公司的立场反映了对TaskUs在不断发展的AI服务市场中利用其优势的能力的信心。 Morgan ...

Morgan Stanley analyst Alex Straton lowered the firm’s price target on Nike (NKE) to $80 from $82 and keeps an Equal Weight ...

Morgan Stanley has recently reduced FREYR Battery Inc (FREY) stock rating, as announced on November 14, 2023, according to Finviz. Earlier, on November 10, 2023, BTIG Research had reduced the stock ...

Morgan Stanley的修正受到Immunocore的bretantafusp药物数据结果不如预期的影响,特别是今年早些时候在皮肤黑色素瘤和卵巢癌试验中的表现。尽管遇到这些挫折,公司在过去12个月仍保持了25%的强劲收入增长,达到2.96亿美元。

North American Financial 15 Split Corp. (the “Company”) (TSX: FFN, FFN.PR.A) invests in a high-quality portfolio consisting ...

Import prices edged up 0.1% last month after a downwardly revised 0.1% rise in October, the Labor Department's Bureau of ...

TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial ...

Futu Holdings Ltd (FUTU) stock saw a modest uptick, ending the day at $86.54 which represents a slight increase of $1.30 or 1.53% from the prior close of $85.24. The stock opened at $84.5 and touched ...

Broadcom's (AVGO) quarterly results may have topped estimates, but its guidance of up to $90B in revenue from custom AI chips ...